Evidence map›Paper›PMID 25492866›Full record

ArticleThe Journal of biological chemistry2015

Cohen syndrome-associated protein COH1 physically and functionally interacts with the small GTPase RAB6 at the Golgi complex and directs neurite outgrowth.

Wenke Seifert, Jirko Kühnisch, Tanja Maritzen, Stefanie Lommatzsch, Hans Christian Hennies, Sebastian Bachmann, Denise Horn, Volker Haucke

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Impact of genetic test interpretation on aFrontiers in neuroscience · 2024
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wenke SeifertFrom the Institute of Vegetative Anatomy, Charité - Universitätsmedizin Berlin, 10115 Berlin, Germany, wenke.seifert@charite.de.
Jirko KühnischInstitute for Medical and Human Genetics, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany, Max-Planck-Institute for Molecular Genetics, FG Development and Disease, 14195 Berlin, Germany.
Tanja MaritzenDepartment of Molecular Pharmacology and Cell Biology, Leibniz-Institute for Molecular Pharmacology, 13125 Berlin, Germany.
Stefanie LommatzschFrom the Institute of Vegetative Anatomy, Charité - Universitätsmedizin Berlin, 10115 Berlin, Germany.
Hans Christian HenniesCologne Center for Genomics (CCG), University of Cologne, 50931 Cologne, Germany, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany, and the Division of Human Genetics, Innsbruck Medical University, A-6020 Innsbruck, Austria.
Sebastian BachmannFrom the Institute of Vegetative Anatomy, Charité - Universitätsmedizin Berlin, 10115 Berlin, Germany.
Denise HornInstitute for Medical and Human Genetics, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
Volker HauckeDepartment of Molecular Pharmacology and Cell Biology, Leibniz-Institute for Molecular Pharmacology, 13125 Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Postnatal microcephaly, intellectual disability, and progressive retinal dystrophy are major features of autosomal recessive Cohen syndrome, which is caused by mutations in the gene COH1 (VPS13B). We have recently identified COH1 as a Golgi-enriched scaffold protein that contributes to the structural maintenance and function of the Golgi complex. Here, we show that association of COH1 with the Golgi complex depends on the small GTPase RAB6. RNAi-mediated knockdown of RAB6A/A' prevents the localization of COH1 to the Golgi complex. Expression of the constitutively inactive RAB6_T27N mutant led to an increased solubilization of COH1 from lipid membrane preparations. Co-IP experiments confirmed the physical interaction of COH1 with RAB6 that preferentially occurred with the constitutively active RAB6_Q72L mutants. Depletion of COH1 in primary neurons negatively interfered with neurite outgrowth, indicating a causal link between the integrity of the Golgi complex and axonal outgrowth. We conclude that COH1 is a RAB6 effector protein and that reduced brain size in Cohen syndrome patients likely results from impaired COH1 function at the Golgi complex, causing decreased neuritogenesis.

Indexed as

AnimalsCells, CulturedGolgi ApparatusHEK293 CellsHeLa CellsHumansNeuritesProtein BindingProtein Transportrab GTP-Binding ProteinsRatsVesicular Transport ProteinsRab6 proteinrab GTP-Binding ProteinsVesicular Transport ProteinsVPS13B protein, humanCOH1Cohen SyndromeGenetic DiseaseGolgiGTPaseNeurite OutgrowthProtein-Protein InteractionRAB6

Identifiers

PMID25492866
PMCPMC4319006

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.